The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
A double-blind comparison of valproate and lithium in the treatment of acute mania
Abstract
OBJECTIVE: This study was carried out to compare the efficacy of lithium carbonate with that of valproate in acute mania and to determine whether pretreatment clinical characteristics, such as the presence of a mixed affective state, might predict a differential response to the two drugs. METHOD: Twenty-seven patients meeting DSM-III-R criteria for acute manic episodes underwent a 3-week, randomized, double-blind, parallel-groups trial of treatment with lithium carbonate or valproate. Symptom severity was measured by using the Schedule for Affective Disorders and Schizophrenia, change version (SADS-C), the Global Assessment Scale (GAS), and the Brief Psychiatric Rating Scale (BPRS). Drug effects were compared by using repeated measures analysis of variance (ANOVA). RESULTS: At the end of the study, nine of 14 patients treated with valproate and 12 of 13 patients treated with lithium had responded favorably, as measured by changes in the SADS-C mania, BPRS, and GAS scores. Elevated pretreatment SADS-C depression scores were associated with good response to valproate. ANOVA revealed a significant interaction between drug and mixed affective state with respect to treatment response. CONCLUSIONS: Lithium and valproate were both effective in improving manic symptoms, and lithium was slightly more efficacious overall. Unlike the case with lithium, favorable response to valproate was associated with high pretreatment depression scores. Therefore, treatment with valproate alone may be particularly effective in manic patients with mixed affective states.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Clinical Factors in Lithium Carbonate Prophylaxis Failure
Dunner, D. L. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760080077013 · Cited by 514
Valproic acid hepatic fatalities: A retrospective review
Dreifuss, F. E., Santilli, N., Langer, D. H., Sweeney, K. P., Moline, K. A., & Menander, K. B. (1987) · Neurology · doi:10.1212/wnl.37.3.379 · Cited by 483
Valproatereatment of Acute Mania: A Placebo-Controlled
Pope, H. G. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250064008 · Cited by 460
Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.4.431 · Cited by 266
Correlates of antimanic response to carbamazepine
Post, R. M., Uhde, T. W., Roy-Byrne, P. P., & Joffe, R. T. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90064-3 · Cited by 178
The use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders
Emrich, H. M., Dose, M., & von Zerssen, D. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90022-9 · Cited by 176
Sources of lithium resistance in mixed mania.
Himmelhoch, J. M., & Garfinkel, M. E. (1986) · PubMed · Cited by 165
Prien, R. F., Himmelhoch, J. M., & Kupfer, D. J. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90003-1 · Cited by 148
Secunda, S. K., Katz, M. M., Swann, A. C., Koslow, S. H., Maas, J. W., Chuang, S., & Croughan, J. L. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90033-3 · Cited by 112
Cited by
What Is a “Mood Stabilizer”? An Evidence-Based Response
Bauer, M. S., & Mitchner, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.3 · Cited by 862
Practice Guideline for the Treatment of Patients With Bipolar Disorder (Revision)
Hirschfeld, R. M. A., Bowden, C. L., Gitlin, M. J., Keck, P. E., Perlis, R. H., Suppes, T., Thase, M. E., & Wagner, K. D. (2003) · Focus · doi:10.1176/foc.1.1.64 · Cited by 585
Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.12.1633 · Cited by 433
Mechanisms of action of valproate: a commentatory
Johannessen, C. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(00)00013-9 · Cited by 399
Yatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S., MacQueen, G., McIntyre, R., Sharma, V., Silverstone, P., Alda, M., Baruch, P., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00219.x · Cited by 388
Depression During Mania: Treatment Response to Lithium or Divalproex
Swann, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130041008 · Cited by 374
Arndt, T. L., Stodgell, C. J., & Rodier, P. M. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.11.001 · Cited by 360
Management of treatment resistance in schizophrenia
Conley, R. R., & Kelly, D. L. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01271-9 · Cited by 352
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., WFSBP Task Force on Treatment Guide, Grunze, H., Vieta, E., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970902823202 · Cited by 346
Axelson, D., Birmaher, B. J., Brent, D., Wassick, S., Hoover, C., Bridge, J., & Ryan, N. (2003) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454603322724850 · Cited by 309
Gender differences in bipolar disorder
Arnold, L. M. (2003) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(03)00036-4 · Cited by 272
Kane, J. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601043340109 · Cited by 272
Bowden, C. L. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00031.x · Cited by 258
Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Azorin, J.-M., Yatham, L., Mosolov, S., Möller, H.-J., Kasper, S., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1384850 · Cited by 187
“The study by Freeman et al. (1992) was the first controlled study that indicated that valproate was effective in the treatment of depressive symptoms that occurred concomitantly in patients with mania.”
BackgroundSong, J., Sjölander, A., Joas, E., Bergen, S. E., Runeson, B., Larsson, H., Landén, M., & Lichtenstein, P. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.16050542 · Cited by 147
Fountoulakis, K. N., Tohen, M., & Zarate, C. A. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2021.10.003 · Cited by 146
Yildiz, A., Nikodem, M., Vieta, E., Correll, C. U., & Baldessarini, R. J. (2015) · Psychological Medicine · doi:10.1017/s0033291714001305 · Cited by 128
Kessing, L. V., Hellmund, G., Geddes, J. R., Goodwin, G. M., & Andersen, P. K. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.084822 · Cited by 105
Predictors of Response to Mood Stabilizers
CALABRESE, J. R., FATEMI, S. H., KUJAWA, M., & WOYSHVILLE, M. J. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604001-00004 · Cited by 95
Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01356.x · Cited by 90
Treatment of bipolar disorder: a complex treatment for a multi-faceted disorder
Fountoulakis, K. N., Vieta, E., Siamouli, M., Valenti, M., Magiria, S., Oral, T., Fresno, D., Giannakopoulos, P., & Kaprinis, G. S. (2007) · Annals of General Psychiatry · doi:10.1186/1744-859x-6-27 · Cited by 76
Treatment of mixed bipolar states
Fountoulakis, K. N., Kontis, D., Gonda, X., Siamouli, M., & Yatham, L. N. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001817 · Cited by 68
Acute and prophylactic effects of anticonvulsants in bipolar depression
Post, R. M., Speer, A. M., Obrocea, G. V., & Leverich, G. S. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00047-6 · Cited by 20
Pharmacological treatment of mixed states
Cuomo, A., Nikolova, V. L., Yalin, N., Arnone, D., Fagiolini, A., & Young, A. H. (2017) · CNS Spectrums · doi:10.1017/s1092852917000013 · Cited by 14
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1992-01-01
- Volume
- 149
- Issue
- 1
- Pages
- 108-111
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W183228308
- Cited by
- 301
- References
- 13
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.